{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T15:26:14Z","timestamp":1785252374408,"version":"3.55.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,3,10]],"date-time":"2020-03-10T00:00:00Z","timestamp":1583798400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,3,10]],"date-time":"2020-03-10T00:00:00Z","timestamp":1583798400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod Biol Endocrinol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Introduction<\/jats:title>\n                <jats:p>Antimullerian hormone (AMH) strongly correlates with ovarian reserve and response to controlled ovarian stimulation. Emerging data suggests that serum AMH level may also predict ART outcomes. However, AMH is characteristically elevated in PCOS women and it is unknown whether it may predict live birth outcomes in this population.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This was a retrospective cohort study of 184 PCOS women (Rotterdam criteria) who underwent their first fresh IVF\/ICSI cycle. Women were divided into 3 groups according to the &lt;25th (low), 25 to 75th (average), or\u2009&gt;\u200975th (high) percentile of serum AMH concentration. Cycle stimulation parameters and reproductive outcomes were compared between groups.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Women in the low serum AMH group were older than those in the average or high AMH (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05), and required greater gonadotropin dose for stimulation compared to the high AMH group (p\u2009&lt;\u20090.05). Women with high AMH had greater testosterone level compared to women in the low or average AMH groups. No differences were noted between groups in terms of maximal E2, oocytes retrieved and fertilization rate. However, low serum AMH women had significantly greater live birth rates (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05) and showed a trend towards greater clinical pregnancy rates compared to women in the average and high AMH groups (<jats:italic>p<\/jats:italic>\u2009=\u20090.09). The significant association of AMH with live birth rate remained after adjusting for age, BMI, day of transfer and number of embryos transferred.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>In PCOS women, elevated AMH concentrations are associated with hyperandrogenism and lower live birth rates.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12958-020-00581-4","type":"journal-article","created":{"date-parts":[[2020,3,10]],"date-time":"2020-03-10T13:03:08Z","timestamp":1583845388000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["High serum Antimullerian hormone levels are associated with lower live birth rates in women with polycystic ovarian syndrome undergoing assisted reproductive technology"],"prefix":"10.1186","volume":"18","author":[{"given":"Reshef","family":"Tal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles M.","family":"Seifer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moisey","family":"Khanimov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David B.","family":"Seifer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oded","family":"Tal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,10]]},"reference":[{"key":"581_CR1","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1093\/humupd\/dmp036","volume":"16","author":"A La Marca","year":"2010","unstructured":"La Marca A, Sighinolfi G, Radi D, Argento C, Baraldi E, Artenisio AC, Stabile G, Volpe A. Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART). Hum Reprod Update. 2010;16:113\u201330.","journal-title":"Hum Reprod Update"},{"key":"581_CR2","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.ajog.2017.02.027","volume":"217","author":"R Tal","year":"2017","unstructured":"Tal R, Seifer DB. Ovarian reserve testing: a user's guide. Am J Obstet Gynecol. 2017;217:129\u201340.","journal-title":"Am J Obstet Gynecol"},{"key":"581_CR3","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1530\/rep.0.1240601","volume":"124","author":"AL Durlinger","year":"2002","unstructured":"Durlinger AL, Visser JA, Themmen AP. Regulation of ovarian function: the role of anti-Mullerian hormone. Reproduction. 2002;124:601\u20139.","journal-title":"Reproduction"},{"key":"581_CR4","doi-asserted-by":"crossref","unstructured":"Rotterdam EA-SPCWG: Revised 2003 Consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004, 81:19\u201325.","DOI":"10.1016\/j.fertnstert.2003.10.004"},{"key":"581_CR5","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1210\/jc.2006-1582","volume":"92","author":"L Pellatt","year":"2007","unstructured":"Pellatt L, Hanna L, Brincat M, Galea R, Brain H, Whitehead S, Mason H. Granulosa cell production of anti-Mullerian hormone is increased in polycystic ovaries. J Clin Endocrinol Metab. 2007;92:240\u20135.","journal-title":"J Clin Endocrinol Metab"},{"key":"581_CR6","doi-asserted-by":"publisher","first-page":"3123","DOI":"10.1093\/humrep\/der297","volume":"26","author":"D Dewailly","year":"2011","unstructured":"Dewailly D, Gronier H, Poncelet E, Robin G, Leroy M, Pigny P, Duhamel A, Catteau-Jonard S. Diagnosis of polycystic ovary syndrome (PCOS): revisiting the threshold values of follicle count on ultrasound and of the serum AMH level for the definition of polycystic ovaries. Hum Reprod. 2011;26:3123\u20139.","journal-title":"Hum Reprod"},{"key":"581_CR7","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.fertnstert.2011.04.003","volume":"96","author":"YH Lin","year":"2011","unstructured":"Lin YH, Chiu WC, Wu CH, Tzeng CR, Hsu CS, Hsu MI. Antimullerian hormone and polycystic ovary syndrome. Fertil Steril. 2011;96:230\u20135.","journal-title":"Fertil Steril"},{"key":"581_CR8","doi-asserted-by":"publisher","first-page":"2917","DOI":"10.1093\/humrep\/dep225","volume":"24","author":"LG Nardo","year":"2009","unstructured":"Nardo LG, Yates AP, Roberts SA, Pemberton P, Laing I. The relationships between AMH, androgens, insulin resistance and basal ovarian follicular status in non-obese subfertile women with and without polycystic ovary syndrome. Hum Reprod. 2009;24:2917\u201323.","journal-title":"Hum Reprod"},{"key":"581_CR9","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1210\/jc.2005-2076","volume":"91","author":"P Pigny","year":"2006","unstructured":"Pigny P, Jonard S, Robert Y, Dewailly D. Serum anti-Mullerian hormone as a surrogate for antral follicle count for definition of the polycystic ovary syndrome. J Clin Endocrinol Metab. 2006;91:941\u20135.","journal-title":"J Clin Endocrinol Metab"},{"key":"581_CR10","doi-asserted-by":"publisher","first-page":"E238","DOI":"10.1152\/ajpendo.90684.2008","volume":"296","author":"A Piouka","year":"2009","unstructured":"Piouka A, Farmakiotis D, Katsikis I, Macut D, Gerou S, Panidis D. Anti-Mullerian hormone levels reflect severity of PCOS but are negatively influenced by obesity: relationship with increased luteinizing hormone levels. Am J Physiol Endocrinol Metab. 2009;296:E238\u201343.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"581_CR11","doi-asserted-by":"publisher","first-page":"59 e51","DOI":"10.1016\/j.ajog.2014.02.026","volume":"211","author":"R Tal","year":"2014","unstructured":"Tal R, Seifer DB, Khanimov M, Malter HE, Grazi RV, Leader B. Characterization of women with elevated antimullerian hormone levels (AMH): correlation of AMH with polycystic ovarian syndrome phenotypes and assisted reproductive technology outcomes. Am J Obstet Gynecol. 2014;211:59 e51\u20138.","journal-title":"Am J Obstet Gynecol"},{"key":"581_CR12","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1016\/j.fertnstert.2004.08.004","volume":"82","author":"A La Marca","year":"2004","unstructured":"La Marca A, Orvieto R, Giulini S, Jasonni VM, Volpe A, De Leo V. Mullerian-inhibiting substance in women with polycystic ovary syndrome: relationship with hormonal and metabolic characteristics. Fertil Steril. 2004;82:970\u20132.","journal-title":"Fertil Steril"},{"key":"581_CR13","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1210\/jc.2012-3676","volume":"98","author":"T Brodin","year":"2013","unstructured":"Brodin T, Hadziosmanovic N, Berglund L, Olovsson M, Holte J. Antimullerian hormone levels are strongly associated with live-birth rates after assisted reproduction. J Clin Endocrinol Metab. 2013;98:1107\u201314.","journal-title":"J Clin Endocrinol Metab"},{"key":"581_CR14","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1093\/humupd\/dmu003","volume":"20","author":"S Iliodromiti","year":"2014","unstructured":"Iliodromiti S, Kelsey TW, Wu O, Anderson RA, Nelson SM. The predictive accuracy of anti-Mullerian hormone for live birth after assisted conception: a systematic review and meta-analysis of the literature. Hum Reprod Update. 2014;20:560\u201370.","journal-title":"Hum Reprod Update"},{"key":"581_CR15","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.fertnstert.2014.09.041","volume":"103","author":"R Tal","year":"2015","unstructured":"Tal R, Tal O, Seifer BJ, Seifer DB. Antimullerian hormone as predictor of implantation and clinical pregnancy after assisted conception: a systematic review and meta-analysis. Fertil Steril. 2015;103:119\u201330 e113.","journal-title":"Fertil Steril"},{"key":"581_CR16","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.1016\/j.fertnstert.2009.12.002","volume":"94","author":"C Kaya","year":"2010","unstructured":"Kaya C, Pabuccu R, Satiroglu H. Serum antimullerian hormone concentrations on day 3 of the in vitro fertilization stimulation cycle are predictive of the fertilization, implantation, and pregnancy in polycystic ovary syndrome patients undergoing assisted reproduction. Fertil Steril. 2010;94:2202\u20137.","journal-title":"Fertil Steril"},{"key":"581_CR17","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s10815-012-9726-x","volume":"29","author":"W Xi","year":"2012","unstructured":"Xi W, Gong F, Lu G. Correlation of serum anti-Mullerian hormone concentrations on day 3 of the in vitro fertilization stimulation cycle with assisted reproduction outcome in polycystic ovary syndrome patients. J Assist Reprod Genet. 2012;29:397\u2013402.","journal-title":"J Assist Reprod Genet"},{"key":"581_CR18","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1093\/humrep\/dev131","volume":"30","author":"MS Alebic","year":"2015","unstructured":"Alebic MS, Stojanovic N, Duhamel A, Dewailly D. The phenotypic diversity in per-follicle anti-Mullerian hormone production in polycystic ovary syndrome. Hum Reprod. 2015;30:1927\u201333.","journal-title":"Hum Reprod"},{"key":"581_CR19","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.rbmo.2018.05.003","volume":"37","author":"M De Vos","year":"2018","unstructured":"De Vos M, Pareyn S, Drakopoulos P, Raimundo JM, Anckaert E, Santos-Ribeiro S, Polyzos NP, Tournaye H, Blockeel C. Cumulative live birth rates after IVF in patients with polycystic ovaries: phenotype matters. Reprod BioMed Online. 2018;37:163\u201371.","journal-title":"Reprod BioMed Online"},{"key":"581_CR20","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.rbmo.2016.01.010","volume":"32","author":"F Ramezanali","year":"2016","unstructured":"Ramezanali F, Ashrafi M, Hemat M, Arabipoor A, Jalali S, Moini A. Assisted reproductive outcomes in women with different polycystic ovary syndrome phenotypes: the predictive value of anti-Mullerian hormone. Reprod BioMed Online. 2016;32:503\u201312.","journal-title":"Reprod BioMed Online"},{"key":"581_CR21","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/j.fertnstert.2010.10.011","volume":"95","author":"DB Seifer","year":"2011","unstructured":"Seifer DB, Baker VL, Leader B. Age-specific serum anti-Mullerian hormone values for 17,120 women presenting to fertility centers within the United States. Fertil Steril. 2011;95:747\u201350.","journal-title":"Fertil Steril"},{"key":"581_CR22","doi-asserted-by":"publisher","first-page":"2364","DOI":"10.1016\/j.fertnstert.2011.03.081","volume":"95","author":"E Buyuk","year":"2011","unstructured":"Buyuk E, Seifer DB, Illions E, Grazi RV, Lieman H. Elevated body mass index is associated with lower serum anti-mullerian hormone levels in infertile women with diminished ovarian reserve but not with normal ovarian reserve. Fertil Steril. 2011;95:2364\u20138.","journal-title":"Fertil Steril"},{"key":"581_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0022024","volume":"6","author":"TW Kelsey","year":"2011","unstructured":"Kelsey TW, Wright P, Nelson SM, Anderson RA, Wallace WH. A validated model of serum anti-mullerian hormone from conception to menopause. PLoS One. 2011;6:e22024.","journal-title":"PLoS One"},{"key":"581_CR24","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/S0015-0282(01)03201-0","volume":"77","author":"DB Seifer","year":"2002","unstructured":"Seifer DB, MacLaughlin DT, Christian BP, Feng B, Shelden RM. Early follicular serum mullerian-inhibiting substance levels are associated with ovarian response during assisted reproductive technology cycles. Fertil Steril. 2002;77:468\u201371.","journal-title":"Fertil Steril"},{"key":"581_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1530\/rep.1.00529","volume":"131","author":"JA Visser","year":"2006","unstructured":"Visser JA, de Jong FH, Laven JS, Themmen AP. Anti-Mullerian hormone: a new marker for ovarian function. Reproduction. 2006;131:1\u20139.","journal-title":"Reproduction"},{"key":"581_CR26","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1530\/REP-09-0415","volume":"139","author":"L Pellatt","year":"2010","unstructured":"Pellatt L, Rice S, Mason HD. Anti-Mullerian hormone and polycystic ovary syndrome: a mountain too high? Reproduction. 2010;139:825\u201333.","journal-title":"Reproduction"},{"key":"581_CR27","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.rbmo.2016.04.007","volume":"33","author":"D Garg","year":"2016","unstructured":"Garg D, Tal R. The role of AMH in the pathophysiology of polycystic ovarian syndrome. Reprod BioMed Online. 2016;33:15\u201328.","journal-title":"Reprod BioMed Online"},{"key":"581_CR28","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1093\/humupd\/dmh010","volume":"10","author":"S Jonard","year":"2004","unstructured":"Jonard S, Dewailly D. The follicular excess in polycystic ovaries, due to intra-ovarian hyperandrogenism, may be the main culprit for the follicular arrest. Hum Reprod Update. 2004;10:107\u201317.","journal-title":"Hum Reprod Update"},{"key":"581_CR29","doi-asserted-by":"publisher","first-page":"5957","DOI":"10.1210\/jc.2003-030727","volume":"88","author":"P Pigny","year":"2003","unstructured":"Pigny P, Merlen E, Robert Y, Cortet-Rudelli C, Decanter C, Jonard S, Dewailly D. Elevated serum level of anti-mullerian hormone in patients with polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest. J Clin Endocrinol Metab. 2003;88:5957\u201362.","journal-title":"J Clin Endocrinol Metab"},{"key":"581_CR30","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1016\/j.fertnstert.2007.03.066","volume":"89","author":"MP Grossman","year":"2008","unstructured":"Grossman MP, Nakajima ST, Fallat ME, Siow Y. Mullerian-inhibiting substance inhibits cytochrome P450 aromatase activity in human granulosa lutein cell culture. Fertil Steril. 2008;89:1364\u201370.","journal-title":"Fertil Steril"},{"key":"581_CR31","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1016\/j.fertnstert.2011.08.015","volume":"96","author":"L Pellatt","year":"2011","unstructured":"Pellatt L, Rice S, Dilaver N, Heshri A, Galea R, Brincat M, Brown K, Simpson ER, Mason HD. Anti-Mullerian hormone reduces follicle sensitivity to follicle-stimulating hormone in human granulosa cells. Fertil Steril. 2011;96:1246\u201351 e1241.","journal-title":"Fertil Steril"},{"key":"581_CR32","doi-asserted-by":"publisher","first-page":"2622","DOI":"10.1172\/JCI2081","volume":"101","author":"KA Vendola","year":"1998","unstructured":"Vendola KA, Zhou J, Adesanya OO, Weil SJ, Bondy CA. Androgens stimulate early stages of follicular growth in the primate ovary. J Clin Invest. 1998;101:2622\u20139.","journal-title":"J Clin Invest"},{"key":"581_CR33","doi-asserted-by":"publisher","first-page":"2951","DOI":"10.1210\/jcem.84.8.5929","volume":"84","author":"S Weil","year":"1999","unstructured":"Weil S, Vendola K, Zhou J, Bondy CA. Androgen and follicle-stimulating hormone interactions in primate ovarian follicle development. J Clin Endocrinol Metab. 1999;84:2951\u20136.","journal-title":"J Clin Endocrinol Metab"},{"key":"581_CR34","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1093\/humupd\/dmq032","volume":"17","author":"J Qiao","year":"2011","unstructured":"Qiao J, Feng HL. Extra- and intra-ovarian factors in polycystic ovary syndrome: impact on oocyte maturation and embryo developmental competence. Hum Reprod Update. 2011;17:17\u201333.","journal-title":"Hum Reprod Update"},{"key":"581_CR35","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1093\/humrep\/deg266","volume":"18","author":"M Filicori","year":"2003","unstructured":"Filicori M, Cognigni GE, Ciampaglia W. Effects of LH on oocyte yield and developmental competence. Hum Reprod. 2003;18:1357\u20138 author reply 1358-1360.","journal-title":"Hum Reprod"},{"key":"581_CR36","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1177\/1933719115618283","volume":"23","author":"C Rosas","year":"2016","unstructured":"Rosas C, Orostica L, Poblete C, Carvajal R, Gabler F, Romero C, Lavandero S, Vega M. Hyperandrogenism decreases GRP78 protein level and glucose uptake in human endometrial stromal cells. Reprod Sci. 2016;23:761\u201370.","journal-title":"Reprod Sci"},{"key":"581_CR37","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1055\/s-0035-1552582","volume":"33","author":"R Tal","year":"2015","unstructured":"Tal R, Seifer DB, Arici A. The emerging role of angiogenic factor dysregulation in the pathogenesis of polycystic ovarian syndrome. Semin Reprod Med. 2015;33:195\u2013207.","journal-title":"Semin Reprod Med"},{"key":"581_CR38","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1016\/j.fertnstert.2008.01.028","volume":"91","author":"J Wang","year":"2009","unstructured":"Wang J, Dicken C, Lustbader JW, Tortoriello DV. Evidence for a Mullerian-inhibiting substance autocrine\/paracrine system in adult human endometrium. Fertil Steril. 2009;91:1195\u2013203.","journal-title":"Fertil Steril"},{"key":"581_CR39","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1016\/j.fertnstert.2014.01.052","volume":"101","author":"P Carrarelli","year":"2014","unstructured":"Carrarelli P, Rocha AL, Belmonte G, Zupi E, Abrao MS, Arcuri F, Piomboni P, Petraglia F. Increased expression of antimullerian hormone and its receptor in endometriosis. Fertil Steril. 2014;101:1353\u20138.","journal-title":"Fertil Steril"},{"key":"581_CR40","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/1756-9966-33-46","volume":"33","author":"PG Signorile","year":"2014","unstructured":"Signorile PG, Petraglia F, Baldi A. Anti-mullerian hormone is expressed by endometriosis tissues and induces cell cycle arrest and apoptosis in endometriosis cells. J Exp Clin Cancer Res. 2014;33:46.","journal-title":"J Exp Clin Cancer Res"},{"key":"581_CR41","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1007\/s00404-019-05359-7","volume":"300","author":"A Gaba","year":"2019","unstructured":"Gaba A, Horath S, Hager M, Marculescu R, Ott J. Basal anti Mullerian hormone levels and endometrial thickness at midcycle can predict the outcome after clomiphene citrate stimulation in anovulatory women with PCOS, a retrospective study. Arch Gynecol Obstet. 2019;300:1751\u20137.","journal-title":"Arch Gynecol Obstet"},{"key":"581_CR42","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1056\/NEJMoa1513873","volume":"375","author":"ZJ Chen","year":"2016","unstructured":"Chen ZJ, Shi Y, Sun Y, Zhang B, Liang X, Cao Y, Yang J, Liu J, Wei D, Weng N, et al. Fresh versus frozen embryos for infertility in the polycystic ovary syndrome. N Engl J Med. 2016;375:523\u201333.","journal-title":"N Engl J Med"}],"container-title":["Reproductive Biology and Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12958-020-00581-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12958-020-00581-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12958-020-00581-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,10]],"date-time":"2021-03-10T00:12:40Z","timestamp":1615335160000},"score":1,"resource":{"primary":{"URL":"https:\/\/rbej.biomedcentral.com\/articles\/10.1186\/s12958-020-00581-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,10]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["581"],"URL":"https:\/\/doi.org\/10.1186\/s12958-020-00581-4","relation":{},"ISSN":["1477-7827"],"issn-type":[{"value":"1477-7827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,10]]},"assertion":[{"value":"2 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Approval for this study was obtained from the Institutional Review Board (IRB) of Maimonides Medical Center.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"David B. Seifer <i>receives<\/i> a <i>royalty<\/i> from a licensing agreement between <i>UMDNJ<\/i>\/Massachusetts General Hospital and Beckman-Coulter for the use of AMH in determining ovarian reserve. All other authors have no competing interests to report.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20"}}